David L. Brown

Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema

Q. Nguyen, Y. Shildkrot, D. Do, 2019, International Journal of Retina and Vitreous.

Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies.

P. Mitchell, F. Asmus, Y. Ogura, 2019, Ophthalmology Retina.

Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial.

C. Wykoff, F. Asmus, N. Waheed, 2019, Ophthalmology.

Vascularized drusen: a cross-sectional study

J. Fujimoto, N. Waheed, A. Y. Alibhai, 2019, International journal of retina and vitreous.

Randomized, Double-masked, Active-controlled Phase 3 Trial Of The Efficacy And Safety Of Intravitreal VEGF Trap-Eye In Wet AMD: One-year Results Of The View-1 Study

A. Ho, P. Kaiser, Q. Nguyen, 2011 .

Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.

Justis P. Ehlers, P. Kaiser, S. Srivastava, 2019, Ophthalmology. Retina.

Intravitreal Aflibercept Injection (IAI) for Diabetic Macular Edema (DME): Primary and Additional Endpoint Results from the 12-Month Phase 3 VISTA-DME and VIVID-DME Studies

David L. Brown, 2014 .

Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial.

Ivana K. Kim, T. Ciulla, J. Heier, 2011, Ophthalmology.